In breast cancer, a recent study demonstrated that minor subclones expressing IL11 and FIGF (or VEGFD) indirectly cooperate to promote metastatic progression by modulating bone-marrow-derived mesenchymal stromal cells. The gene discussed is VEGFD; the disease is breast carcinoma.